English
Insider transactions
EDGARBiohaven Ltd.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–30 of 30
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 Filed 2026-09-17 | Gentile Kimberly Officer: SVP, Clinical Operations | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,000 | 0 | — | 1,000 | Indirect (I) By Son | No | F1, F2
| Open filing 0001704186-26-000006 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | Mehta Kishan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001850520-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | Heffernan Michael Thomas Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001448914-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | HUGIN ROBERT J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001232505-26-000003 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | Antonijevic Irina Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001926476-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | GREGORY JULIA P Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001226675-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | Bailey Gregory Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001329505-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-28 Filed 2026-04-30 | CHILDS JOHN W Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 68,693 | 0 | — | 68,693 | Direct (D) | No | F1
| Open filing 0001027035-26-000008 Read from the filing’s XML Dispute this row |
| 2026-03-17 Filed 2026-03-19 | Mehta Kishan Director | GBona fide gift | Disposed (D) | 17,342 | 0 | — | 5,320 | Direct (D) | No | — | Open filing 0001850520-26-000003 Read from the filing’s XML Dispute this row |
| 2026-03-17 Filed 2026-03-19 | Mehta Kishan Director | GBona fide gift | Acquired (A) | 17,342 | 0 | — | 17,342 | Indirect (I) By Kishen Mehta 21 Family Irrevocable Trust | No | F1
| Open filing 0001850520-26-000003 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Car Bruce Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 175,000 | 0 | — | 175,000 | Direct (D) | No | F1
| Open filing 0001798876-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Gentile Kimberly Officer: SVP, Clinical Operations | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 175,000 | 0 | — | 175,000 | Direct (D) | No | F1
| Open filing 0001704186-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Buten Matthew Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 175,000 | 0 | — | 175,000 | Direct (D) | No | F1
| Open filing 0001898799-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Coric Vlad Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 550,000 | 0 | — | 550,000 | Direct (D) | No | F1
| Open filing 0001704317-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-03 | Clark George C. Officer: VP, Chief Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001878290-26-000004 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Car Bruce Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 4,750 | 0 | — | 10,096 | Direct (D) | No | F1
| Open filing 0001798876-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Car Bruce Officer: Chief Scientific Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,381 | 9.93 | 23,643.33Derived: shares × price per share. Exact value 23643.33. | 7,715 | Direct (D) | No | F2, F1
| Open filing 0001798876-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Car Bruce Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,750 | 0 | — | 9,500 | Direct (D) | No | F3, F4, F5
| Open filing 0001798876-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Clark George C. Officer: VP, Chief Accounting Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 2,500 | 0 | — | 68,095 | Direct (D) | No | — | Open filing 0001878290-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Clark George C. Officer: VP, Chief Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,117 | 9.93 | 11,091.81Derived: shares × price per share. Exact value 11091.81. | 66,978 | Direct (D) | No | F1
| Open filing 0001878290-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Clark George C. Officer: VP, Chief Accounting Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 2,500 | 0 | — | 5,000 | Direct (D) | No | F2, F3, F4
| Open filing 0001878290-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Buten Matthew Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 4,250 | 0 | — | 198,246 | Direct (D) | No | F1
| Open filing 0001898799-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Buten Matthew Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,594 | 9.93 | 25,758.42Derived: shares × price per share. Exact value 25758.42. | 195,652 | Direct (D) | No | F2, F1
| Open filing 0001898799-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Buten Matthew Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,250 | 0 | — | 8,500 | Direct (D) | No | F3, F4, F5
| Open filing 0001898799-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Coric Vlad Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 14,250 | 0 | — | 1,811,398 | Direct (D) | No | — | Open filing 0001704317-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Coric Vlad Director · Officer: Chief Executive Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 7,430 | 9.93 | 73,779.9Derived: shares × price per share. Exact value 73779.90. | 1,803,968 | Direct (D) | No | F1
| Open filing 0001704317-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Coric Vlad Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 14,250 | 0 | — | 28,500 | Direct (D) | No | F3, F4, F5
| Open filing 0001704317-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Gentile Kimberly Officer: SVP, Clinical Operations | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,750 | 0 | — | 101,513 | Direct (D) | No | — | Open filing 0001704186-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Gentile Kimberly Officer: SVP, Clinical Operations | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,956 | 9.93 | 19,423.08Derived: shares × price per share. Exact value 19423.08. | 99,557 | Direct (D) | No | F1
| Open filing 0001704186-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-05 Filed 2026-01-07 | Gentile Kimberly Officer: SVP, Clinical Operations | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,750 | 0 | — | 7,500 | Direct (D) | No | F2, F3, F4
| Open filing 0001704186-26-000002 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–50 of 326
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| BlackRock, Inc. Partly reported under another manager | 12,951,180 SH | 172,898,253 dollars | Lower by 259,405 Prior quarter: 13,210,585 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| MONTANOVA CAPITAL, LLC | 10,286,937 SH | 137,330,609 dollars | Unchanged Prior quarter: 10,286,937 | Open filing 0001172661-26-005325 Filed 2026-11-16 Dispute this row |
| STIFEL FINANCIAL CORP Partly reported under another manager | 9,941,685 SH | 132,721,494 dollars | Higher by 520 Prior quarter: 9,941,165 | Open filing 0000720672-26-000017 Filed 2026-11-12 Dispute this row |
| Woodline Partners LP | 7,660,635 SH | 102,269,477 dollars | Higher by 355 Prior quarter: 7,660,280 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 6,874,721 SH | 91,777,525 dollars | Lower by 72,313 Prior quarter: 6,947,034 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| INFINITUM ASSET MANAGEMENT, LLC | 6,250,000 SH | 83,437,500 dollars | Unchanged Prior quarter: 6,250,000 | Open filing 0002058093-26-000010 Filed 2026-11-16 Dispute this row |
| Rubric Capital Management LP | 4,875,000 SH | 65,081,250 dollars | Higher by 3,153,507 Prior quarter: 1,721,493 | Open filing 0001104659-26-128244 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 4,077,524 SH | 54,434,947 dollars | Higher by 2,599,686 Prior quarter: 1,477,838 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 4,053,232 SH | 54,110,641 dollars | Lower by 97,384 Prior quarter: 4,150,616 | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 3,728,221 SH | 49,771,750 dollars | Higher by 1,145,175 Prior quarter: 2,583,046 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 3,725,210 SH | 49,731,554 dollars | Lower by 464,985 Prior quarter: 4,190,195 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,250,000 SH | 43,387,500 dollars | Higher by 2,250,000 Prior quarter: 1,000,000 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 2,937,515 SH | 39,215,826 dollars | Higher by 418,688 Prior quarter: 2,518,827 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Royalty Pharma Sub-Manager, LLC Partly reported under another manager | 2,936,507 SH | 39,202,368 dollars | Unchanged Prior quarter: 2,936,507 | Open filing 0002081668-26-000021 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 2,891,378 SH | 38,609,664 dollars | Lower by 431,812 Prior quarter: 3,323,190 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| FMR LLC Partly reported under another manager | 2,574,373 SH | 34,367,861 dollars | Lower by 390,257 Prior quarter: 2,964,630 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 2,521,538 SH | 33,662,532 dollars | Higher by 777,204 Prior quarter: 1,744,334 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,502,667 SH | 33,410,604 dollars | Higher by 13,726 Prior quarter: 2,488,941 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 2,036,196 SH | 27,182,871 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
| Cormorant Asset Management, LP Partly reported under another manager | 1,510,000 SH | 20,158,500 dollars | Lower by 1,100,000 Prior quarter: 2,610,000 | Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 1,449,608 SH | 19,353 dollars | Lower by 7,243 Prior quarter: 1,456,851 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,402,311 SH | 18,720,852 dollars | Lower by 86,498 Prior quarter: 1,488,809 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| ARS Investment Partners, LLC | 1,372,668 SH | 18,325,118 dollars | Lower by 1,517 Prior quarter: 1,374,185 | Open filing 0001172661-26-004872 Filed 2026-11-05 Dispute this row |
| Balyasny Asset Management L.P. | 1,341,024 SH | 17,902,670 dollars | Lower by 538,710 Prior quarter: 1,879,734 | Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row |
| ALGERT GLOBAL LLC Partly reported under another manager | 1,291,773 SH | 17,245,170 dollars | Higher by 982,793 Prior quarter: 308,980 | Open filing 0001275218-26-000018 Filed 2026-11-17 Dispute this row |
| TCG Crossover Management, LLC | 1,262,423 SH | 16,853,347 dollars | Lower by 517,529 Prior quarter: 1,779,952 | Open filing 0001214659-26-014306 Filed 2026-11-16 Dispute this row |
| Capital Research Global Investors Partly reported under another manager | 1,199,545 SH | 16,013,926 dollars | Unchanged Prior quarter: 1,199,545 | Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row |
| Opaleye Management Inc. | 1,190,000 SH | 15,886,500 dollars | Higher by 1,112,085 Prior quarter: 77,915 | Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 1,189,537 SH | 15,880,318 dollars | Higher by 3,326 Prior quarter: 1,186,211 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| MYDA Advisors LLC | 1,150,000 SH | 15,352,500 dollars | Unchanged Prior quarter: 1,150,000 | Open filing 0001214659-26-014141 Filed 2026-11-13 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,139,120 SH | 15,207,252 dollars | Higher by 29,837 Prior quarter: 1,109,283 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| TORONTO DOMINION BANK | 1,118,548 SH | 14,932,616 dollars | Higher by 1,020,191 Prior quarter: 98,357 | Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row |
| Logos Global Management LP | 1,100,000 SH | 14,685,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005128 Filed 2026-11-16 Dispute this row |
| Logos Global Management LP Option: Call | 1,000,000 SH | 13,350,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005128 Filed 2026-11-16 Dispute this row |
| Caption Management, LLC Option: Call | 960,800 SH | 12,826,680 dollars | Higher by 485,800 Prior quarter: 475,000 | Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 873,217 SH | 11,657,462 dollars | Higher by 31,866 Prior quarter: 841,351 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Qube Research Technologies Ltd | 833,568 SH | 11,128,133 dollars | Lower by 72,367 Prior quarter: 905,935 | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 796,370 SH | 10,631,540 dollars | Lower by 32,409 Prior quarter: 828,779 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 793,100 SH | 10,587,885 dollars | Higher by 135,800 Prior quarter: 657,300 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| Capricorn Fund Managers Ltd Partly reported under another manager | 764,801 SH | 10,210,093 dollars | Not in the prior quarter’s filings read | Open filing 0001901361-26-000016 Filed 2026-11-03 Dispute this row |
| 5AM Venture Management, LLC | 738,972 SH | 9,865,276 dollars | Unchanged Prior quarter: 738,972 | Open filing 0001799883-26-000004 Filed 2026-11-16 Dispute this row |
| Erste Asset Management GmbH | 737,300 SH | 9,798,717 dollars | Unchanged Prior quarter: 737,300 | Open filing 0001398344-26-019910 Filed 2026-11-12 Dispute this row |
| Longaeva Partners L.P. Partly reported under another manager | 671,576 SH | 8,965,540 dollars | Higher by 71,673 Prior quarter: 599,903 | Open filing 0001193125-26-463222 Filed 2026-11-16 Dispute this row |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 670,955 SH | 8,957,249 dollars | Lower by 211,769 Prior quarter: 882,724 | Open filing 0001556921-26-000010 Filed 2026-11-16 Dispute this row |
| Sarissa Capital Management LP | 582,312 SH | 7,773,865 dollars | Unchanged Prior quarter: 582,312 | Open filing 0001420506-26-002892 Filed 2026-11-16 Dispute this row |
| Simplify Asset Management Inc. | 550,693 SH | 7,351,752 dollars | Lower by 489,562 Prior quarter: 1,040,255 | Open filing 0001172661-26-004722 Filed 2026-10-27 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 545,162 SH | 7,342,140 dollars | Higher by 75,330 Prior quarter: 469,832 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager | 540,310 SH | 7,213,138 dollars | Higher by 539,562 Prior quarter: 748 | Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row |
| SummitTX Capital, L.P. | 532,414 SH | 7,107,727 dollars | Not in the prior quarter’s filings read | Open filing 0002052310-26-000008 Filed 2026-11-16 Dispute this row |
| Pfizer Inc | 505,645 SH | 6,568,329 dollars | Unchanged Prior quarter: 505,645 | Open filing 0000078003-26-000135 Filed 2026-11-12 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Jupiter Topco LLC 8,584,675 SH
- CITADEL ADVISORS LLC 1,619,676 SH
- Sixth Street Partners Management Company, L.P. 1,109,283 SH
- Eversept Partners, LP 515,804 SH
- Trexquant Investment LP 503,694 SH
- STEMPOINT CAPITAL LP 500,000 SH
- Point72 Asset Management, L.P. 491,918 SH
- Aberdeen Group plc 365,519 SH
- Affinity Asset Advisors, LLC 250,000 SH
- NewEdge Wealth, LLC 245,670 SH
- XTX Topco Ltd 170,163 SH
- SPHERA FUNDS MANAGEMENT LTD. 164,437 SH
- SG Americas Securities, LLC 101,920 SH
- VIRGINIA RETIREMENT SYSTEMS ET Al 88,400 SH
- Voleon Capital Management LP 74,798 SH
- Schonfeld Strategic Advisors LLC 72,396 SH
- Aquatic Capital Management LLC 50,585 SH
- CAPITAL FUND MANAGEMENT S.A. 47,097 SH
- Greenland Capital Management LP 46,000 SH
- AXQ CAPITAL, LP 45,891 SH
- OPTIMIZE FINANCIAL INC. 44,524 SH
- Sound Capital Solutions LLC 44,524 SH
- Jain Global LLC 34,858 SH
- Greenland Capital Management LP 30,000 SH
- INTECH INVESTMENT MANAGEMENT LLC 27,859 SH
- Headlands Technologies LLC 26,339 SH
- SIMPLEX TRADING, LLC 23,317 SH
- Morgan Creek Capital Management, LLC 18,193 SH
- OXFORD ASSET MANAGEMENT LLP 17,871 SH
- GTS SECURITIES LLC 16,988 SH
- Centiva Capital, LP 16,722 SH
- MAI Capital Management 14,099 SH
- Quantbot Technologies LP 13,132 SH
- WADDELL ASSOCIATES, LLC 10,351 SH
- BlueCrest Capital Management Ltd 4,000 SH
- Pacer Advisors, Inc. 1,760 SH
- AdvisorNet Financial, Inc 500 SH
- Wealth Enhancement Trust Services, Inc. 369 SH
- Aster Capital Management (DIFC) Ltd 334 SH
- Optiver Holding B.V. 328 SH
- Private Wealth Asset Management, LLC 200 SH
- SHP Wealth Management 100 SH
- Ares Financial Consulting, LLC 84 SH
- BESSEMER GROUP INC 79 SH
- BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 72 SH
- Ameritas Advisory Services, LLC 24 SH
- Park Place Capital Corp 19 SH
- Stone House Investment Management, LLC 16 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP Ltd. Common Shares | 1.4 | 2,036,197 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001274173-26-000262 Dispute this row |
| Woodline Partners LP Common Shares, no par value per share | 5.1 | 7,660,280.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0000919574-26-005259 Dispute this row |
| JANUS HENDERSON GROUP Ltd. Common Shares | 5.7 | 8,584,676 | 06/30/2026 Filed 2026-07-08 | SCHEDULE 13G/AAmendment 2 | Open filing 0001274173-26-000170 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Shares | 11.7 | 17,534,612 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001274173-26-000140 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Shares | 12.7 | 16,803,459 | 01/30/2026 Filed 2026-02-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001274173-26-000045 Dispute this row |
| SUVRETTA CAPITAL MANAGEMENT, LLC Common Shares, no par value | 7.8 | 10,286,937.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-000942 Dispute this row |
| AVERILL MASTER FUND, LTD. Common Shares, no par value | 6.6 | 8,800,438.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-000942 Dispute this row |
| AARON COWEN Common Shares, no par value | 7.8 | 10,286,937.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-000942 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Stock | 6.4 | 6,772,113 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0001274173-25-000271 Dispute this row |
| The Vanguard Group Common Stock | 2.71 | 2,875,190 | 09/30/2025 Filed 2025-10-30 | SCHEDULE 13G/AAmendment 1 | Open filing 0000102909-25-000041 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Stock | 4.9 | 5,053,528 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001274173-25-000199 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,556,900 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 183,193 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.